~~<i id='3F21A1ED48'><strike id='3F21A1ED48'><tt id='3F21A1ED48'><pre id='3F21A1ED48'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

explore

author：focus 2025-09-30 00:50:37 - browse：765

Limor Appelbaum, radiation oncologist and a researcher working on the effort to predict pancreatic cancer for early detection, using AI analysis of vast amounts of electronic health records. -- health coverage from STAT — Suzanne Kreiter/Globe staff

Limor Appelbaum has seen too many patients whose first sign of a fatal illness came too late.

Often it’s yellowed eyes from jaundice, caused by a cancerous tumor on the pancreas that has grown so large it presses against the bile duct system. By this point, little can be done. “All we can really offer them is something that can prolong life by a few months,” and comfort care, said Appelbaum, a staff scientist at Beth Israel Deaconess Medical Center.

Only 11 percent of people diagnosed with pancreatic cancer are alive five years later.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： PBM reforms clear House panel

focus

leisure time

entertainment

focus

leisure time

Wikipedia

AdobeThreemonthsago,myauntMargarethadastroke.Daysbefore,shewasrepaintingherbathroomanddrivingherself

WSS

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Anthos stroke drug appears safer than common blood thinner

Some medical students still think black patients feel less pain

A daunting task: navigating dual Medicare, Medicaid eligibility

Decentralized clinical trials need collaboration to achieve wider use

entertainment

explore

focus

ChatGPT in medicine: STAT answers readers' burning questions

Some medical students still think black patients feel less pain

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Peter Hotez and the public health issue of online harassment

Gain of function research would be limited under House proposal

The high cost of giving birth even with insurance

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

23andMe had bad news about my health. I wish a person had delivered it

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

leisure time

Congress must reauthorize a committee to support older Americans

Clinicians often fail to acknowledge the pain caused by long Covid

Anthos stroke drug appears safer than common blood thinner

Why some fertility treatments produce more boy babies

Unmasking the 'centricity' illusion in clinical trials

Hospitals need to get ahead of regulations on climate change

entertainment

focus

leisure time

Wikipedia